Profilo

Mr. Uhl has covered the healthcare sector for roughly 20 years as an analyst and director of research on both the buy-side and the sell-side.
Mr. Uhl joined FBR in October 2004 as senior vice president and senior analyst covering the specialty pharmaceutical sector, which includes generic, drug delivery, and therapeutically focused small-cap and mid-cap pharmaceutical companies.
His investment approach seeks out companies with unique differentiable products, a business plan that makes sense, a capable management team that can execute effectively, and a justifiable valuation.
Mr. Uhl previously covered the sector at Wells Fargo Securities; Leerink Swann & Company, a Boston-based healthcare investment banking boutique; Salomon Brothers; and Curran Capital Management, a healthcare hedge fund.
Mr. Uhl received his B.S.
in microbiology from Purdue University and his M.B.A.
in international business from the University of South Carolina.

Precedenti posizioni note di Robert H. Uhl

SocietàPosizioneFine
Analyst-Equity 30/04/2008
Vedi nel dettaglio l'esperienza di Robert H. Uhl

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Robert H. Uhl

Relazioni

100 +

Relazioni di 1° grado

1

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private1

Finance

Vedi le connessioni aziendali